Skip to main content

Table 2 Summary of study visits, procedures, and evaluations

From: Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease

  At inclusion Day 1 Between day 30–60 At 6 months Monthly for first 12 months Every 3 months thereafter
NaF- or PSMA- PET CT (with CT of chest/abdomen/pelvis) x      
PSA, total testosterone x     x x
Radical prostatectomy   x     
SBRT to all sites of metastases    x    
Prostate bed/nodes RT a       
Lupron depot (6 month)b   x     
Start apalutamide, abiraterone acetate, prednisone b   x     
Stop apalutamide, abiraterone acetate, taper prednisone     x   
Quality-of-life and toxicity assessments x     x x
  1. aif indicated, This pelvic RT can extend beyond or be completed after ADT
  2. bwithin 3 days of surgery